Strong Q2 and H1 FY27 results, Solstice extension and FY28-FY29 revenue target

Multi-year targets disclosedOrder pipeline disclosedInvestor Communications View source PDF Explain this filing

NAVINFLUOR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.1%Reaction day

₹8823.00

prior close

₹8908.50

announcement price

In-mkt

timing

Nifty Smallcap 250marketpendingvs market: pending

Specialty Chemicals peers, median of 101sector-0.6%+2.7% vs sector

On the reaction day the stock moved 2.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.1

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.1pendingpending-0.6+2.7

Next day

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 101Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY27 revenue rose 57% year on year to INR1,191 crore; operating EBITDA was INR407 crore at a 34.2% margin, and profit after tax was INR269 crore. H1 profit was INR513 crore and EPS INR100; dividend INR8 per share. The Solstice fluorochemical deal runs to December 2032 and may add about USD180 million of revenue. CDMO order visibility is near USD100 million, while two plants target INR900-1,000 crore of annual revenue by FY28-FY29.

Likely market impact

Strong results, a long-term contract and the dividend may support the share price, but project execution and heavy capital spending remain risks.